ID   ACTB_MOUSE              Reviewed;         375 AA.
AC   P60710; P02570; P70514; P99021; Q11211; Q3TI89; Q3TVP6; Q64316; Q6ZWM3;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1988, sequence version 1.
DT   18-JUN-2025, entry version 197.
DE   RecName: Full=Actin, cytoplasmic 1;
DE   AltName: Full=Beta-actin;
DE            EC=3.6.4.- {ECO:0000250|UniProtKB:P68137};
DE   Contains:
DE     RecName: Full=Actin, cytoplasmic 1, N-terminally processed;
GN   Name=Actb;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3754329; DOI=10.1093/nar/14.6.2829;
RA   Tokunaga K., Taniguchi H., Yoda K., Shimizu M., Sakiyama S.;
RT   "Nucleotide sequence of a full-length cDNA for mouse cytoskeletal beta-
RT   actin mRNA.";
RL   Nucleic Acids Res. 14:2829-2829(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=BALB/cJ, C57BL/6J, and NOD;
RC   TISSUE=Bone marrow, Mammary gland, and Thymus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   PROTEIN SEQUENCE OF 2-375, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT
RP   ASP-2, AND METHYLATION AT HIS-73.
RC   TISSUE=Thymus;
RX   PubMed=213279; DOI=10.1111/j.1432-1033.1978.tb12624.x;
RA   Vandekerckhove J., Weber K.;
RT   "Actin amino-acid sequences. Comparison of actins from calf thymus, bovine
RT   brain, and SV40-transformed mouse 3T3 cells with rabbit skeletal muscle
RT   actin.";
RL   Eur. J. Biochem. 90:451-462(1978).
RN   [4]
RP   PROTEIN SEQUENCE OF 19-39; 51-61; 85-113; 148-177; 184-191; 197-206;
RP   216-254; 257-284; 291-326 AND 360-372, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   STRAIN=C57BL/6J, and OF1; TISSUE=Brain, and Hippocampus;
RA   Lubec G., Klug S., Kang S.U., Sunyer B., Chen W.-Q.;
RL   Submitted (JAN-2009) to UniProtKB.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 27-375.
RX   PubMed=3084797; DOI=10.1007/bf02100994;
RA   Alonso S., Minty A., Bourlet Y., Buckingham M.;
RT   "Comparison of three actin-coding sequences in the mouse; evolutionary
RT   relationships between the actin genes of warm-blooded vertebrates.";
RL   J. Mol. Evol. 23:11-22(1986).
RN   [6]
RP   ACETYLATION.
RC   TISSUE=Muscle;
RA   Vilbois F.;
RL   Submitted (OCT-1998) to UniProtKB.
RN   [7]
RP   INTERACTION WITH CPNE1 AND CPNE4.
RX   PubMed=12522145; DOI=10.1074/jbc.m212632200;
RA   Tomsig J.L., Snyder S.L., Creutz C.E.;
RT   "Identification of targets for calcium signaling through the copine family
RT   of proteins. Characterization of a coiled-coil copine-binding motif.";
RL   J. Biol. Chem. 278:10048-10054(2003).
RN   [8]
RP   ISGYLATION.
RX   PubMed=16139798; DOI=10.1016/j.bbrc.2005.08.132;
RA   Giannakopoulos N.V., Luo J.K., Papov V., Zou W., Lenschow D.J.,
RA   Jacobs B.S., Borden E.C., Li J., Virgin H.W., Zhang D.E.;
RT   "Proteomic identification of proteins conjugated to ISG15 in mouse and
RT   human cells.";
RL   Biochem. Biophys. Res. Commun. 336:496-506(2005).
RN   [9]
RP   INTERACTION WITH TBC1D21.
RX   PubMed=21128978; DOI=10.1111/j.1365-2605.2010.01126.x;
RA   Lin Y.H., Lin Y.M., Kuo Y.C., Wang Y.Y., Kuo P.L.;
RT   "Identification and characterization of a novel Rab GTPase-activating
RT   protein in spermatids.";
RL   Int. J. Androl. 34:E358-E367(2011).
RN   [10]
RP   INTERACTION WITH FAM107A.
RX   PubMed=21969592; DOI=10.1073/pnas.1103318108;
RA   Schmidt M.V., Schuelke J.P., Liebl C., Stiess M., Avrabos C., Bock J.,
RA   Wochnik G.M., Davies H.A., Zimmermann N., Scharf S.H., Truembach D.,
RA   Wurst W., Zieglgaensberger W., Turck C., Holsboer F., Stewart M.G.,
RA   Bradke F., Eder M., Mueller M.B., Rein T.;
RT   "Tumor suppressor down-regulated in renal cell carcinoma 1 (DRR1) is a
RT   stress-induced actin bundling factor that modulates synaptic efficacy and
RT   cognition.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:17213-17218(2011).
RN   [11]
RP   OXIDATION AT MET-44 AND MET-47, AND DEOXIDATION AT MET-44 AND MET-47.
RX   PubMed=23911929; DOI=10.1016/j.molcel.2013.06.019;
RA   Lee B.C., Peterfi Z., Hoffmann F.W., Moore R.E., Kaya A., Avanesov A.,
RA   Tarrago L., Zhou Y., Weerapana E., Fomenko D.E., Hoffmann P.R.,
RA   Gladyshev V.N.;
RT   "MsrB1 and MICALs regulate actin assembly and macrophage function via
RT   reversible stereoselective methionine oxidation.";
RL   Mol. Cell 51:397-404(2013).
RN   [12]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23558171; DOI=10.1126/science.1235038;
RA   Baarlink C., Wang H., Grosse R.;
RT   "Nuclear actin network assembly by formins regulates the SRF coactivator
RT   MAL.";
RL   Science 340:864-867(2013).
RN   [13]
RP   INTERACTION WITH AMOTL2.
RX   PubMed=24806444; DOI=10.1038/ncomms4743;
RA   Hultin S., Zheng Y., Mojallal M., Vertuani S., Gentili C., Balland M.,
RA   Milloud R., Belting H.G., Affolter M., Helker C.S., Adams R.H., Herzog W.,
RA   Uhlen P., Majumdar A., Holmgren L.;
RT   "AmotL2 links VE-cadherin to contractile actin fibres necessary for aortic
RT   lumen expansion.";
RL   Nat. Commun. 5:3743-3743(2014).
RN   [14]
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=25759381; DOI=10.1074/jbc.m114.627166;
RA   Plessner M., Melak M., Chinchilla P., Baarlink C., Grosse R.;
RT   "Nuclear F-actin formation and reorganization upon cell spreading.";
RL   J. Biol. Chem. 290:11209-11216(2015).
RN   [15]
RP   TISSUE SPECIFICITY.
RX   PubMed=30659401; DOI=10.1007/s10735-019-09813-3;
RA   Sharma S., Hanukoglu I.;
RT   "Mapping the sites of localization of epithelial sodium channel (ENaC) and
RT   CFTR in segments of the mammalian epididymis.";
RL   J. Mol. Histol. 50:141-154(2019).
RN   [16]
RP   METHYLATION AT HIS-73.
RX   PubMed=30626964; DOI=10.1038/s41586-018-0821-8;
RA   Wilkinson A.W., Diep J., Dai S., Liu S., Ooi Y.S., Song D., Li T.M.,
RA   Horton J.R., Zhang X., Liu C., Trivedi D.V., Ruppel K.M.,
RA   Vilches-Moure J.G., Casey K.M., Mak J., Cowan T., Elias J.E.,
RA   Nagamine C.M., Spudich J.A., Cheng X., Carette J.E., Gozani O.;
RT   "SETD3 is an actin histidine methyltransferase that prevents primary
RT   dystocia.";
RL   Nature 565:372-376(2019).
RN   [17]
RP   TISSUE SPECIFICITY.
RX   PubMed=31605441; DOI=10.1111/febs.15088;
RA   Kumaran G.K., Hanukoglu I.;
RT   "Identification and classification of epithelial cells in nephron segments
RT   by actin cytoskeleton patterns.";
RL   FEBS J. 287:1176-1194(2020).
RN   [18]
RP   INTERACTION WITH TPRN.
RX   PubMed=37952086; DOI=10.1016/j.ymthe.2023.11.011;
RA   Qi J., Tan F., Zhang L., Zhou Y., Zhang Z., Sun Q., Li N., Fang Y.,
RA   Chen X., Wu Y., Zhong G., Chai R.;
RT   "Critical role of TPRN rings in the stereocilia for hearing.";
RL   Mol. Ther. 32:204-217(2024).
CC   -!- FUNCTION: Actin is a highly conserved protein that polymerizes to
CC       produce filaments that form cross-linked networks in the cytoplasm of
CC       cells (By similarity). Actin exists in both monomeric (G-actin) and
CC       polymeric (F-actin) forms, both forms playing key functions, such as
CC       cell motility and contraction (By similarity). In addition to their
CC       role in the cytoplasmic cytoskeleton, G- and F-actin also localize in
CC       the nucleus, and regulate gene transcription and motility and repair of
CC       damaged DNA (PubMed:23558171, PubMed:25759381). Plays a role in the
CC       assembly of the gamma-tubulin ring complex (gTuRC), which regulates the
CC       minus-end nucleation of alpha-beta tubulin heterodimers that grow into
CC       microtubule protafilaments (By similarity). Part of the ACTR1A/ACTB
CC       filament around which the dynactin complex is built (By similarity).
CC       The dynactin multiprotein complex activates the molecular motor dynein
CC       for ultra-processive transport along microtubules (By similarity).
CC       {ECO:0000250|UniProtKB:P60709, ECO:0000250|UniProtKB:Q6QAQ1,
CC       ECO:0000269|PubMed:23558171, ECO:0000269|PubMed:25759381}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:P68137};
CC   -!- SUBUNIT: Polymerization of globular actin (G-actin) leads to a
CC       structural filament (F-actin) in the form of a two-stranded helix
CC       (PubMed:25759381). Each actin can bind to 4 others (By similarity).
CC       Identified in a IGF2BP1-dependent mRNP granule complex containing
CC       untranslated mRNAs (By similarity). Component of the BAF complex, which
CC       includes at least actin (ACTB), ARID1A, ARID1B/BAF250, SMARCA2,
CC       SMARCA4/BRG1, ACTL6A/BAF53, ACTL6B/BAF53B, SMARCE1/BAF57
CC       SMARCC1/BAF155, SMARCC2/BAF170, SMARCB1/SNF5/INI1, and one or more of
CC       SMARCD1/BAF60A, SMARCD2/BAF60B, or SMARCD3/BAF60C (By similarity). In
CC       muscle cells, the BAF complex also contains DPF3 (By similarity). Found
CC       in a complex with XPO6, Ran, ACTB and PFN1 (By similarity). Interacts
CC       with PFN1 (By similarity). Interacts with XPO6 and EMD (By similarity).
CC       Interacts with ERBB2 (By similarity). Interacts with GCSAM (By
CC       similarity). Interacts with TBC1D21 (PubMed:21128978). Interacts with
CC       CPNE1 (via VWFA domain) and CPNE4 (via VWFA domain) (PubMed:12522145).
CC       Interacts with DHX9 (via C-terminus); this interaction is direct and
CC       mediates the attachment to nuclear ribonucleoprotein complexes (By
CC       similarity). Interacts with FAM107A (PubMed:21969592). Associates with
CC       the gamma-tubulin ring complex (gTuRC) consisting of TUBGCP2, TUBGCP3,
CC       TUBGCP4, TUBGCP5 and TUBGCP6 and gamma-tubulin TUBG1 or TUBG2; within
CC       the complex, interacts with TUBGCP3 and TUBGCP6 to form a luminal
CC       bridge with MZT1 that stabilizes the initial structure during complex
CC       assembly (By similarity). Part of the ACTR1A/ACTB filament around which
CC       the dynactin complex is built (By similarity). The filament contains 8
CC       copies of ACTR1A and 1 ACTB (By similarity). Interacts with TPRN which
CC       forms ring-like structures in the stereocilium taper region; the
CC       interaction may stabilize stereocilia in inner ear hair cells
CC       (PubMed:37952086). Interacts with AMOTL2 (via N-terminus), the
CC       interaction facilitates binding of cell junction complexes to actin
CC       fibers in endothelial cells (PubMed:24806444).
CC       {ECO:0000250|UniProtKB:P60709, ECO:0000250|UniProtKB:Q6QAQ1,
CC       ECO:0000269|PubMed:12522145, ECO:0000269|PubMed:21128978,
CC       ECO:0000269|PubMed:21969592, ECO:0000269|PubMed:24806444,
CC       ECO:0000269|PubMed:25759381, ECO:0000269|PubMed:37952086}.
CC   -!- INTERACTION:
CC       P60710; P97792: Cxadr; NbExp=6; IntAct=EBI-353957, EBI-7429264;
CC       P60710; Q923J1: Trpm7; NbExp=2; IntAct=EBI-353957, EBI-8010314;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Nucleus
CC       {ECO:0000269|PubMed:23558171, ECO:0000269|PubMed:25759381}.
CC       Note=Localized in cytoplasmic mRNP granules containing untranslated
CC       mRNAs. {ECO:0000250|UniProtKB:P60709}.
CC   -!- TISSUE SPECIFICITY: Expressed in the epididymis (at protein level)
CC       (PubMed:30659401). Expressed in the kidney (at protein level)
CC       (PubMed:31605441). {ECO:0000269|PubMed:30659401,
CC       ECO:0000269|PubMed:31605441}.
CC   -!- PTM: ISGylated. {ECO:0000269|PubMed:16139798}.
CC   -!- PTM: Oxidation of Met-44 and Met-47 by MICALs (MICAL1, MICAL2 or
CC       MICAL3) to form methionine sulfoxide promotes actin filament
CC       depolymerization (PubMed:23911929). MICAL1 and MICAL2 produce the (R)-
CC       S-oxide form. The (R)-S-oxide form is reverted by MSRB1 and MSRB2,
CC       which promote actin repolymerization (PubMed:23911929).
CC       {ECO:0000269|PubMed:23911929}.
CC   -!- PTM: Monomethylation at Lys-84 (K84me1) regulates actin-myosin
CC       interaction and actomyosin-dependent processes. Demethylation by ALKBH4
CC       is required for maintaining actomyosin dynamics supporting normal
CC       cleavage furrow ingression during cytokinesis and cell migration.
CC       {ECO:0000250|UniProtKB:P60709}.
CC   -!- PTM: Methylated at His-73 by SETD3 (PubMed:30626964). Methylation at
CC       His-73 is required for smooth muscle contraction of the laboring uterus
CC       during delivery (PubMed:30626964). {ECO:0000269|PubMed:30626964}.
CC   -!- PTM: [Actin, cytoplasmic 1]: N-terminal cleavage of acetylated
CC       methionine of immature cytoplasmic actin by ACTMAP.
CC       {ECO:0000250|UniProtKB:P60709}.
CC   -!- PTM: [Actin, cytoplasmic 1, N-terminally processed]: N-terminal
CC       acetylation by NAA80 affects actin filament depolymerization and
CC       elongation, including elongation driven by formins. In contrast,
CC       filament nucleation by the Arp2/3 complex is not affected.
CC       {ECO:0000250|UniProtKB:P60709}.
CC   -!- MISCELLANEOUS: In vertebrates 3 main groups of actin isoforms, alpha,
CC       beta and gamma have been identified. The alpha actins are found in
CC       muscle tissues and are a major constituent of the contractile
CC       apparatus. The beta and gamma actins coexist in most cell types as
CC       components of the cytoskeleton and as mediators of internal cell
CC       motility. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the actin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X03672; CAA27307.1; -; mRNA.
DR   EMBL; AK088691; BAC40507.1; -; mRNA.
DR   EMBL; AK145191; BAE26283.1; -; mRNA.
DR   EMBL; AK145196; BAE26288.1; -; mRNA.
DR   EMBL; AK145308; BAE26359.1; -; mRNA.
DR   EMBL; AK150711; BAE29789.1; -; mRNA.
DR   EMBL; AK150879; BAE29928.1; -; mRNA.
DR   EMBL; AK151010; BAE30031.1; -; mRNA.
DR   EMBL; AK151136; BAE30144.1; -; mRNA.
DR   EMBL; AK151145; BAE30152.1; -; mRNA.
DR   EMBL; AK151159; BAE30164.1; -; mRNA.
DR   EMBL; AK151166; BAE30169.1; -; mRNA.
DR   EMBL; AK151190; BAE30187.1; -; mRNA.
DR   EMBL; AK151202; BAE30199.1; -; mRNA.
DR   EMBL; AK151226; BAE30218.1; -; mRNA.
DR   EMBL; AK151277; BAE30264.1; -; mRNA.
DR   EMBL; AK151350; BAE30326.1; -; mRNA.
DR   EMBL; AK151398; BAE30366.1; -; mRNA.
DR   EMBL; AK151995; BAE30859.1; -; mRNA.
DR   EMBL; AK151999; BAE30863.1; -; mRNA.
DR   EMBL; AK152615; BAE31359.1; -; mRNA.
DR   EMBL; AK152651; BAE31388.1; -; mRNA.
DR   EMBL; AK152844; BAE31537.1; -; mRNA.
DR   EMBL; AK159759; BAE35350.1; -; mRNA.
DR   EMBL; AK159834; BAE35412.1; -; mRNA.
DR   EMBL; AK160029; BAE35572.1; -; mRNA.
DR   EMBL; AK166349; BAE38723.1; -; mRNA.
DR   EMBL; AK166498; BAE38810.1; -; mRNA.
DR   EMBL; AK167117; BAE39265.1; -; mRNA.
DR   EMBL; AK167960; BAE39957.1; -; mRNA.
DR   EMBL; X03765; CAA27396.1; -; mRNA.
DR   EMBL; M12481; AAA37144.1; -; mRNA.
DR   CCDS; CCDS19833.1; -.
DR   PIR; A39104; ATMSB.
DR   RefSeq; NP_031419.1; NM_007393.5.
DR   AlphaFoldDB; P60710; -.
DR   SMR; P60710; -.
DR   BioGRID; 197944; 372.
DR   ComplexPortal; CPX-1232; SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6A-ARID1A-SMARCA2 variant.
DR   ComplexPortal; CPX-1233; SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6A-ARID1A-SMARCA4 variant.
DR   ComplexPortal; CPX-1234; SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6A-ARID1B-SMARCA2 variant.
DR   ComplexPortal; CPX-1235; SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6A-ARID1B-SMARCA4 variant.
DR   ComplexPortal; CPX-1236; SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6B-ARID1A-SMARCA2 variant.
DR   ComplexPortal; CPX-1237; SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6B-ARID1A-SMARCA4 variant.
DR   ComplexPortal; CPX-1238; SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6B-ARID1B-SMARCA2 variant.
DR   ComplexPortal; CPX-1239; SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6B-ARID1B-SMARCA4 variant.
DR   ComplexPortal; CPX-1240; Muscle cell-specific SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6A-ARID1A-SMARCA2 variant.
DR   ComplexPortal; CPX-1241; Muscle cell-specific SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6A-ARID1A-SMARCA4 variant.
DR   ComplexPortal; CPX-1242; Muscle cell-specific SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6A-ARID1B-SMARCA2 variant.
DR   ComplexPortal; CPX-1243; Muscle cell-specific SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6A-ARID1B-SMARCA4 variant.
DR   ComplexPortal; CPX-1244; Muscle cell-specific SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6B-ARID1A-SMARCA2 variant.
DR   ComplexPortal; CPX-1245; Muscle cell-specific SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6B-ARID1A-SMARCA4 variant.
DR   ComplexPortal; CPX-1246; Muscle cell-specific SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6B-ARID1B-SMARCA2 variant.
DR   ComplexPortal; CPX-1247; Muscle cell-specific SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6B-ARID1B-SMARCA4 variant.
DR   ComplexPortal; CPX-1248; Polybromo-associated SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6A variant.
DR   ComplexPortal; CPX-1250; Polybromo-associated SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6B variant.
DR   ComplexPortal; CPX-1251; Embryonic stem cell-specific SWI/SNF ATP-dependent chromatin remodeling complex.
DR   ComplexPortal; CPX-1252; Neural progenitor-specific SWI/SNF ATP-dependent chromatin remodeling complex, ARID1A-SMARCA2 variant.
DR   ComplexPortal; CPX-1253; Neural progenitor-specific SWI/SNF ATP-dependent chromatin remodeling complex, ARID1A-SMARCA4 variant.
DR   ComplexPortal; CPX-1254; Neural progenitor-specific SWI/SNF ATP-dependent chromatin remodeling complex, ARID1B-SMARCA2 variant.
DR   ComplexPortal; CPX-1255; Neural progenitor-specific SWI/SNF ATP-dependent chromatin remodeling complex, ARID1B-SMARCA4 variant.
DR   ComplexPortal; CPX-1256; Neuron-specific SWI/SNF ATP-dependent chromatin remodeling complex, ARID1A-SMARCA2 variant.
DR   ComplexPortal; CPX-1257; Neuron-specific SWI/SNF ATP-dependent chromatin remodeling complex, ARID1A-SMARCA4 variant.
DR   ComplexPortal; CPX-1258; Neuron-specific SWI/SNF ATP-dependent chromatin remodeling complex, ARID1B-SMARCA2 variant.
DR   ComplexPortal; CPX-1259; Neuron-specific SWI/SNF ATP-dependent chromatin remodeling complex, ARID1B-SMARCA4 variant.
DR   ComplexPortal; CPX-1261; Brain-specific SWI/SNF ATP-dependent chromatin remodeling complex, ARID1A-SMARCA2 variant.
DR   ComplexPortal; CPX-1262; Brain-specific SWI/SNF ATP-dependent chromatin remodeling complex, ARID1A-SMARCA4 variant.
DR   ComplexPortal; CPX-1263; Brain-specific SWI/SNF ATP-dependent chromatin remodeling complex, ARID1B-SMARCA2 variant.
DR   ComplexPortal; CPX-1264; Brain-specific SWI/SNF ATP-dependent chromatin remodeling complex, ARID1B-SMARCA4 variant.
DR   ComplexPortal; CPX-4202; GBAF (SWI/SNF) ATP-dependent chromatin remodeling complex, ACTL6A-BICRA-SMARCA2 variant.
DR   ComplexPortal; CPX-4204; GBAF (SWI/SNF) ATP-dependent chromatin remodeling complex, ACTL6A-BICRAL-SMARCA2 variant.
DR   ComplexPortal; CPX-4221; GBAF (SWI/SNF) ATP-dependent chromatin remodeling complex, ACTL6A-BICRA-SMARCA4 variant.
DR   ComplexPortal; CPX-4222; GBAF (SWI/SNF) ATP-dependent chromatin remodeling complex, ACTL6A-BICRAL-SMARCA4 variant.
DR   ComplexPortal; CPX-4227; GBAF (SWI/SNF) ATP-dependent chromatin remodeling complex, ACTL6B-BICRA-SMARCA2 variant.
DR   ComplexPortal; CPX-4228; GBAF (SWI/SNF) ATP-dependent chromatin remodeling complex, ACTL6B-BICRAL-SMARCA2 variant.
DR   ComplexPortal; CPX-4229; GBAF (SWI/SNF) ATP-dependent chromatin remodeling complex, ACTL6B-BICRA-SMARCA4 variant.
DR   ComplexPortal; CPX-4230; GBAF (SWI/SNF) ATP-dependent chromatin remodeling complex, ACTL6B-BICRAL-SMARCA4 variant.
DR   ComplexPortal; CPX-990; NuA4 histone acetyltransferase complex.
DR   CORUM; P60710; -.
DR   DIP; DIP-31574N; -.
DR   FunCoup; P60710; 2331.
DR   IntAct; P60710; 225.
DR   MINT; P60710; -.
DR   STRING; 10090.ENSMUSP00000098066; -.
DR   ChEMBL; CHEMBL5169138; -.
DR   CarbonylDB; P60710; -.
DR   GlyGen; P60710; 8 sites, 1 N-linked glycan (1 site), 1 O-linked glycan (7 sites).
DR   iPTMnet; P60710; -.
DR   PhosphoSitePlus; P60710; -.
DR   SwissPalm; P60710; -.
DR   REPRODUCTION-2DPAGE; P60710; -.
DR   CPTAC; non-CPTAC-3542; -.
DR   jPOST; P60710; -.
DR   PaxDb; 10090-ENSMUSP00000098066; -.
DR   PeptideAtlas; P60710; -.
DR   ProteomicsDB; 285751; -.
DR   Pumba; P60710; -.
DR   TopDownProteomics; P60710; -.
DR   Antibodypedia; 3623; 2078 antibodies from 59 providers.
DR   DNASU; 11461; -.
DR   Ensembl; ENSMUST00000100497.11; ENSMUSP00000098066.5; ENSMUSG00000029580.15.
DR   GeneID; 11461; -.
DR   KEGG; mmu:11461; -.
DR   UCSC; uc009ajk.1; mouse.
DR   AGR; MGI:87904; -.
DR   CTD; 60; -.
DR   MGI; MGI:87904; Actb.
DR   VEuPathDB; HostDB:ENSMUSG00000029580; -.
DR   eggNOG; KOG0676; Eukaryota.
DR   GeneTree; ENSGT00950000182960; -.
DR   InParanoid; P60710; -.
DR   OMA; FHTTAER; -.
DR   OrthoDB; 9546537at2759; -.
DR   PhylomeDB; P60710; -.
DR   Reactome; R-MMU-190873; Gap junction degradation.
DR   Reactome; R-MMU-196025; Formation of annular gap junctions.
DR   Reactome; R-MMU-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-MMU-3928662; EPHB-mediated forward signaling.
DR   Reactome; R-MMU-418990; Adherens junctions interactions.
DR   Reactome; R-MMU-437239; Recycling pathway of L1.
DR   Reactome; R-MMU-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-MMU-445095; Interaction between L1 and Ankyrins.
DR   Reactome; R-MMU-446353; Cell-extracellular matrix interactions.
DR   Reactome; R-MMU-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-MMU-5626467; RHO GTPases activate IQGAPs.
DR   Reactome; R-MMU-5663213; RHO GTPases Activate WASPs and WAVEs.
DR   Reactome; R-MMU-5663220; RHO GTPases Activate Formins.
DR   Reactome; R-MMU-5674135; MAP2K and MAPK activation.
DR   Reactome; R-MMU-5689603; UCH proteinases.
DR   Reactome; R-MMU-5696394; DNA Damage Recognition in GG-NER.
DR   Reactome; R-MMU-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-MMU-9035034; RHOF GTPase cycle.
DR   Reactome; R-MMU-9913351; Formation of the dystrophin-glycoprotein complex (DGC).
DR   BioGRID-ORCS; 11461; 29 hits in 80 CRISPR screens.
DR   CD-CODE; 8F289D40; ELVA.
DR   ChiTaRS; Actb; mouse.
DR   PRO; PR:P60710; -.
DR   Proteomes; UP000000589; Chromosome 5.
DR   RNAct; P60710; protein.
DR   Bgee; ENSMUSG00000029580; Expressed in late embryo and 265 other cell types or tissues.
DR   ExpressionAtlas; P60710; baseline and differential.
DR   GO; GO:0015629; C:actin cytoskeleton; ISS:UniProtKB.
DR   GO; GO:0005912; C:adherens junction; IEA:Ensembl.
DR   GO; GO:0043296; C:apical junction complex; IEA:Ensembl.
DR   GO; GO:0140092; C:bBAF complex; NAS:ComplexPortal.
DR   GO; GO:0035060; C:brahma complex; NAS:ComplexPortal.
DR   GO; GO:0005903; C:brush border; IDA:MGI.
DR   GO; GO:0044305; C:calyx of Held; IDA:SynGO.
DR   GO; GO:0000785; C:chromatin; NAS:ComplexPortal.
DR   GO; GO:0030863; C:cortical cytoskeleton; IDA:MGI.
DR   GO; GO:0005737; C:cytoplasm; IDA:ARUK-UCL.
DR   GO; GO:0036464; C:cytoplasmic ribonucleoprotein granule; IEA:Ensembl.
DR   GO; GO:0005856; C:cytoskeleton; IDA:ARUK-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:MGI.
DR   GO; GO:0097433; C:dense body; ISS:AgBase.
DR   GO; GO:0005925; C:focal adhesion; ISS:AgBase.
DR   GO; GO:0140288; C:GBAF complex; NAS:ComplexPortal.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0000776; C:kinetochore; NAS:ComplexPortal.
DR   GO; GO:0030027; C:lamellipodium; IEA:Ensembl.
DR   GO; GO:0043209; C:myelin sheath; HDA:UniProtKB.
DR   GO; GO:0071565; C:nBAF complex; NAS:ComplexPortal.
DR   GO; GO:0071564; C:npBAF complex; NAS:ComplexPortal.
DR   GO; GO:0035267; C:NuA4 histone acetyltransferase complex; ISO:ComplexPortal.
DR   GO; GO:0016363; C:nuclear matrix; NAS:ComplexPortal.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0000786; C:nucleosome; ISO:ComplexPortal.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; ISS:AgBase.
DR   GO; GO:0098871; C:postsynaptic actin cytoskeleton; IEA:Ensembl.
DR   GO; GO:0032991; C:protein-containing complex; ISS:UniProtKB.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IEA:Ensembl.
DR   GO; GO:0016586; C:RSC-type complex; NAS:ComplexPortal.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; IDA:SynGO.
DR   GO; GO:0016514; C:SWI/SNF complex; NAS:ComplexPortal.
DR   GO; GO:0070160; C:tight junction; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0019894; F:kinesin binding; IEA:Ensembl.
DR   GO; GO:0050998; F:nitric-oxide synthase binding; IEA:Ensembl.
DR   GO; GO:0030235; F:nitric-oxide synthase regulator activity; IEA:Ensembl.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0098973; F:structural constituent of postsynaptic actin cytoskeleton; IEA:Ensembl.
DR   GO; GO:0030957; F:Tat protein binding; IEA:Ensembl.
DR   GO; GO:0141108; F:transporter regulator activity; IEA:Ensembl.
DR   GO; GO:0034333; P:adherens junction assembly; IEA:Ensembl.
DR   GO; GO:0045176; P:apical protein localization; IEA:Ensembl.
DR   GO; GO:0048870; P:cell motility; IEA:Ensembl.
DR   GO; GO:0072749; P:cellular response to cytochalasin B; IEA:Ensembl.
DR   GO; GO:0006338; P:chromatin remodeling; NAS:ComplexPortal.
DR   GO; GO:0007163; P:establishment or maintenance of cell polarity; IEA:Ensembl.
DR   GO; GO:0001738; P:morphogenesis of a polarized epithelium; IEA:Ensembl.
DR   GO; GO:0045596; P:negative regulation of cell differentiation; NAS:ComplexPortal.
DR   GO; GO:0045597; P:positive regulation of cell differentiation; NAS:ComplexPortal.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; NAS:ComplexPortal.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; NAS:ComplexPortal.
DR   GO; GO:2000781; P:positive regulation of double-strand break repair; NAS:ComplexPortal.
DR   GO; GO:1905168; P:positive regulation of double-strand break repair via homologous recombination; ISO:ComplexPortal.
DR   GO; GO:0045663; P:positive regulation of myoblast differentiation; NAS:ComplexPortal.
DR   GO; GO:1902459; P:positive regulation of stem cell population maintenance; NAS:ComplexPortal.
DR   GO; GO:0045582; P:positive regulation of T cell differentiation; NAS:ComplexPortal.
DR   GO; GO:0071896; P:protein localization to adherens junction; IEA:Ensembl.
DR   GO; GO:0042981; P:regulation of apoptotic process; NAS:ComplexPortal.
DR   GO; GO:0051726; P:regulation of cell cycle; ISO:ComplexPortal.
DR   GO; GO:2000779; P:regulation of double-strand break repair; NAS:ComplexPortal.
DR   GO; GO:0070316; P:regulation of G0 to G1 transition; NAS:ComplexPortal.
DR   GO; GO:2000045; P:regulation of G1/S transition of mitotic cell cycle; NAS:ComplexPortal.
DR   GO; GO:0030071; P:regulation of mitotic metaphase/anaphase transition; NAS:ComplexPortal.
DR   GO; GO:0051621; P:regulation of norepinephrine uptake; IEA:Ensembl.
DR   GO; GO:2000819; P:regulation of nucleotide-excision repair; NAS:ComplexPortal.
DR   GO; GO:1903076; P:regulation of protein localization to plasma membrane; IEA:Ensembl.
DR   GO; GO:1900242; P:regulation of synaptic vesicle endocytosis; IDA:SynGO.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; NAS:ComplexPortal.
DR   GO; GO:0150111; P:regulation of transepithelial transport; IEA:Ensembl.
DR   CDD; cd10224; ASKHA_NBD_actin; 1.
DR   FunFam; 3.30.420.40:FF:000131; Actin, alpha skeletal muscle; 1.
DR   FunFam; 3.30.420.40:FF:000291; Actin, alpha skeletal muscle; 1.
DR   FunFam; 3.90.640.10:FF:000047; Actin, alpha skeletal muscle; 1.
DR   FunFam; 3.30.420.40:FF:000058; Putative actin-related protein 5; 1.
DR   Gene3D; 3.30.420.40; -; 2.
DR   Gene3D; 3.90.640.10; Actin, Chain A, domain 4; 1.
DR   InterPro; IPR004000; Actin.
DR   InterPro; IPR020902; Actin/actin-like_CS.
DR   InterPro; IPR004001; Actin_CS.
DR   InterPro; IPR043129; ATPase_NBD.
DR   PANTHER; PTHR11937; ACTIN; 1.
DR   Pfam; PF00022; Actin; 1.
DR   PRINTS; PR00190; ACTIN.
DR   SMART; SM00268; ACTIN; 1.
DR   SUPFAM; SSF53067; Actin-like ATPase domain; 2.
DR   PROSITE; PS00406; ACTINS_1; 1.
DR   PROSITE; PS00432; ACTINS_2; 1.
DR   PROSITE; PS01132; ACTINS_ACT_LIKE; 1.
DR   TreeFam; TF354237; -.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Hydrolase; Methylation; Nucleotide-binding;
KW   Nucleus; Oxidation; Reference proteome; Ubl conjugation.
FT   CHAIN           1..375
FT                   /note="Actin, cytoplasmic 1"
FT                   /id="PRO_0000367076"
FT   INIT_MET        1
FT                   /note="Removed; alternate"
FT                   /evidence="ECO:0000269|PubMed:213279"
FT   CHAIN           2..375
FT                   /note="Actin, cytoplasmic 1, N-terminally processed"
FT                   /id="PRO_0000000775"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:P60709"
FT   MOD_RES         2
FT                   /note="N-acetylaspartate; in Actin, cytoplasmic 1, N-
FT                   terminally processed"
FT                   /evidence="ECO:0000269|PubMed:213279"
FT   MOD_RES         44
FT                   /note="Methionine (R)-sulfoxide"
FT                   /evidence="ECO:0000269|PubMed:23911929"
FT   MOD_RES         47
FT                   /note="Methionine (R)-sulfoxide"
FT                   /evidence="ECO:0000269|PubMed:23911929"
FT   MOD_RES         73
FT                   /note="Tele-methylhistidine"
FT                   /evidence="ECO:0000269|PubMed:213279,
FT                   ECO:0000269|PubMed:30626964"
FT   MOD_RES         84
FT                   /note="N6-methyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P60709"
FT   CONFLICT        38
FT                   /note="P -> S (in Ref. 5; CAA27396/AAA37144)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        52
FT                   /note="S -> F (in Ref. 2; BAE39957)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        80
FT                   /note="D -> E (in Ref. 2; BAE35572)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        109
FT                   /note="P -> T (in Ref. 2; BAE39957)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        156
FT                   /note="G -> R (in Ref. 2; BAE39957)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        178
FT                   /note="L -> V (in Ref. 2; BAE39957)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   375 AA;  41737 MW;  6AFD05CA94E360E2 CRC64;
     MDDDIAALVV DNGSGMCKAG FAGDDAPRAV FPSIVGRPRH QGVMVGMGQK DSYVGDEAQS
     KRGILTLKYP IEHGIVTNWD DMEKIWHHTF YNELRVAPEE HPVLLTEAPL NPKANREKMT
     QIMFETFNTP AMYVAIQAVL SLYASGRTTG IVMDSGDGVT HTVPIYEGYA LPHAILRLDL
     AGRDLTDYLM KILTERGYSF TTTAEREIVR DIKEKLCYVA LDFEQEMATA ASSSSLEKSY
     ELPDGQVITI GNERFRCPEA LFQPSFLGME SCGIHETTFN SIMKCDVDIR KDLYANTVLS
     GGTTMYPGIA DRMQKEITAL APSTMKIKII APPERKYSVW IGGSILASLS TFQQMWISKQ
     EYDESGPSIV HRKCF
//
